10/25/2022Crisis or Opportunity? Biotech Companies Are at A Crossroads in The St...

10/25/2022Clinical Research Opportunities in China and the Path to USFDA Approva...

10/24/2022U.S. Government Seeks to Restrict Biotechnology Cooperation with China...

10/24/2022NASDAQ-listed BIMI Disposes Acquired Chinese Pharma Distributor

10/21/2022CDE Solicits Comments on Draft Provisions for GLP Certification of Dru...

10/21/2022Drug R&D and Product Registration News Digest October 2022 (2)

10/21/2022Recent Executive Moves

10/20/2022CDE Issues the List of Reference Formulations for GQCE Studies (61st B...

10/20/2022IQVIA Forecasts Chinese CMDO Market to Grow 20% CAGR Before 2025

10/19/2022Fitch: US Biomanufacturing Plan Poses Minor Risks to Chinese Pharma CD...

10/19/2022GSK to Focus on Innovative Medicines and Vaccines to Drive Growth in C...

10/19/2022Viva Biotech Buys Hong Kong CRO SYNthesis to Boost Preclinical Offerin...

10/19/2022The Emergence of Commercial Health Insurances as An Access Route to th...

10/18/2022China's Party Congress Promises Continuity, Not Change (AP)

10/18/2022Xi's Work Report to the 20th Party Congress: 5 Takeaways (The Diplomat...

10/18/2022Financing for China Drugmakers Hits the Lowest of the Year (PharmaDJ)

10/18/2022Report of the CPC 20th Congress: Key Messages Related to Healthcare

10/18/2022NMPA Announces Package Insert Revision of Pentoxifylline Injection

10/17/2022NHSA Announces Conclusion of Expert Evaluation for DRDL Inclusion and ...

10/16/2022SMEI: Chinese Terminal Drug Market Growth Slowed to 1.7% in H1/2022

10/14/2022Singapore Is Becoming a Hotspot for Chinese Drugmakers Looking to Go P...

10/14/2022NMPA Temporarily Extends Timeline for Supplementing Materials of Drug ...

10/14/2022Helsinn Pulls the Plug on Its $2.4B Liver Cancer Deal with BridgeBio

10/14/2022Recent Executive Moves

10/14/2022Drug R&D and Product Registration News Digest October 2022 (1)

10/13/2022IASO and Cabaletta Announce Global License Deal for Clinically Validat...

10/12/2022Cracking the Code to Commercial Promise in Asia (PharmExec)

10/11/2022AI Poised to Take Chinese Drug Discovery to the Next Level

10/11/2022Immune-Onc Therapeutics Enters into Clinical Collaboration with BeiGen...

10/11/2022HanAll's Licensed Partner in China Enters Sublicense Deal with CSPC to...

Page:139/789 Total number of articles:23668: [First][<<] [137] [138] [139] [140] [141] [>>] [End]